首页> 外文期刊>The Open Respiratory Medicine Journal >Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation
【24h】

Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation

机译:脯氨酸-甘氨酸-脯氨酸(PGP)和高迁移率族盒蛋白-1(HMGB1):囊性纤维化气道炎症的潜在药物

获取原文
获取外文期刊封面目录资料

摘要

Cystic fibrosis (CF) is chronic lung disease characterized by an unrelenting neutrophil-predominant airway inflammatory response. This inflammation leads to extracellular matrix (ECM) remodeling and eventually to the development of bronchiectasis. While many components of the immune response in CF have been well-characterized, recent data suggests that small molecules may play an important and underappreciated role in this inflammation. This review will examine two novel molecules: proline-glycine-proline (PGP) and high mobility group box protein-1 (HMGB1), and their potential impact in CF lung disease. This review will provide a brief overview of CF lung disease and background on both HMGB1 and PGP. It will then focus on these molecules in a murine model of CF-like airway disease and in human biological specimens from CF individuals. Finally, this manuscript will address possible mechanisms for therapeutic targeting of these bioactive mediators.
机译:囊性纤维化(CF)是一种慢性肺部疾病,其特征是中性粒细胞为主的气道炎症反应无情。这种炎症导致细胞外基质(ECM)重塑,并最终导致支气管扩张。尽管CF中免疫应答的许多成分已被很好地表征,但最近的数据表明,小分子可能在这种炎症中起着重要而未被充分认识的作用。这篇综述将研究两种新型分子:脯氨酸-甘氨酸-脯氨酸(PGP)和高迁移率基盒蛋白1(HMGB1),以及它们对CF肺疾病的潜在影响。本文将简要概述HMGB1和PGP的CF肺疾病和背景。然后,它将在CF样气道疾病的鼠模型中以及CF个人的人体生物学标本中关注这些分子。最后,该手稿将探讨这些生物活性介质治疗靶向的可能机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号